Eucabal (acetylcysteine) syrup 100 ml. vial


Manufacturer: Germany

Treatment of acute and chronic diseases of the bronchopulmonary system that require reducing the viscosity of sputum, improving its discharge and expectoration.



Eucabal 100 ml Storage
active substances: 100 g of syrup contain: liquid extract of plantain

(Extractum Plantaginis liquidum) (1: 2- 2.5) 3 g, liquid extract of thyme (Thymi liquidum) (1: 2-2.5) 15 g;

Excipients: methyl parahydroxybenzoate (E 218), propyl parahydroxybenzoate

(E 216), invert sugar syrup (glucose monohydrate, fructose, sucrose, purified water).

Eucabal 100 ml Dosage form

Basic physical and chemical properties. Dark brown liquid from clear to cloudy.

Eucabal 100 ml Pharmacotherapeutic group
Remedies used for coughs and colds. ATX code R05C A10.

Pharmacological properties


Substances contained in liquid extracts of both plantain and thyme (thyme), in particular essential oils, as expectorants affect the properties, formation and transport of bronchial secretions.

There is both an indirect reflex effect through the gastric mucosa and a direct effect of essential oils on the bronchial glands, which enhances their activity. This helps to increase, thin and dissolve bronchial secretions, as well as increase the transport of secretions through the ciliated epithelium. This is especially important in the later stages of acute bronchitis and in chronic bronchitis, when there is increased secretion of viscous mucus by the submucosal glands. In addition, essential oils due to their surface activity reduce the binding capacity of highly viscous mucus on the tracheobronchial mucosa.

Thyme is characterized by a pronounced antimicrobial potential of thymol and carvacrol. Plant mucous substances of plantain help protect the damaged bronchial mucosa from further irritation.


Not studied.

Symptomatic treatment of inflammatory diseases of the respiratory tract. An expectorant for the symptomatic treatment of productive cough. Supportive agent for whooping cough.

Hypersensitivity to the components of the drug, fructose intolerance; hypersensitivity to alkyl-4-hydroxybenzoates. Hypersensitivity to plants of the family Lamiaceae, celery and birch pollen (possible cross-reaction).

Gastroesophageal reflux disease, including reflux esophagitis, gastritis with high acidity of gastric juice, gastric and duodenal ulcers, severe liver or kidney disease.

Special security measures
Shake the syrup in a vial before use. The presence of components of plant origin in the drug can cause turbidity of the syrup, but the therapeutic efficacy of the drug is not reduced.

The drug Eucabal® syrup contains 6.5 vol. % ethanol, which poses a risk to patients with epilepsy, chronic alcoholism, liver disease, organic brain diseases.

Do not use in patients with fructose intolerance, impaired glucose-galactose absorption or sucrose-isomaltose. Due to the sugar content it can be harmful to teeth (caries).

At the first signs of hypersensitivity reactions, the drug should not be continued.

Use with caution in patients with diabetes.